These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 18978408)
1. The use of antifibrinolytic agents in spine surgery. A meta-analysis. Gill JB; Chin Y; Levin A; Feng D J Bone Joint Surg Am; 2008 Nov; 90(11):2399-407. PubMed ID: 18978408 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of antifibrinolytic agents on surgical bleeding and transfusion requirements in spine surgery: a meta-analysis. Li G; Sun TW; Luo G; Zhang C Eur Spine J; 2017 Jan; 26(1):140-154. PubMed ID: 27671279 [TBL] [Abstract][Full Text] [Related]
4. Antifibrinolytics reduce blood loss in adult spinal deformity surgery: a prospective, randomized controlled trial. Peters A; Verma K; Slobodyanyuk K; Cheriyan T; Hoelscher C; Schwab F; Lonner B; Huncke T; Lafage V; Errico T Spine (Phila Pa 1976); 2015 Apr; 40(8):E443-9. PubMed ID: 25868100 [TBL] [Abstract][Full Text] [Related]
5. [Effectiveness of tranexamic acid in routine performance of total knee replacement surgery]. Camarasa Godoy MA; Serra-Prat M; Palomera Fanegas E Rev Esp Anestesiol Reanim; 2008 Feb; 55(2):75-80. PubMed ID: 18383968 [TBL] [Abstract][Full Text] [Related]
6. Antifibrinolytics in major orthopaedic surgery. Eubanks JD J Am Acad Orthop Surg; 2010 Mar; 18(3):132-8. PubMed ID: 20190103 [TBL] [Abstract][Full Text] [Related]
7. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis. Henry D; Carless P; Fergusson D; Laupacis A CMAJ; 2009 Jan; 180(2):183-93. PubMed ID: 19050037 [TBL] [Abstract][Full Text] [Related]
8. The use of antifibrinolytic agents in total hip arthroplasty: a meta-analysis. Gill JB; Rosenstein A J Arthroplasty; 2006 Sep; 21(6):869-73. PubMed ID: 16950041 [TBL] [Abstract][Full Text] [Related]
9. Antifibrinolytic agents reduce blood loss during pediatric vertebral column resection procedures. Newton PO; Bastrom TP; Emans JB; Shah SA; Shufflebarger HL; Sponseller PD; Sucato DJ; Lenke LG Spine (Phila Pa 1976); 2012 Nov; 37(23):E1459-63. PubMed ID: 22872217 [TBL] [Abstract][Full Text] [Related]
10. Antifibrinolytic therapy in complex spine surgery: a case-control study comparing aprotinin and tranexamic acid. Colomina MJ; Bagó J; Vidal X; Mora L; Pellisé F Orthopedics; 2009 Feb; 32(2):91. PubMed ID: 19301800 [TBL] [Abstract][Full Text] [Related]
11. Can we safely reduce blood loss during lumbar pedicle subtraction osteotomy procedures using tranexamic acid or aprotinin? A comparative study with controls. Baldus CR; Bridwell KH; Lenke LG; Okubadejo GO Spine (Phila Pa 1976); 2010 Jan; 35(2):235-9. PubMed ID: 20081519 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of antifibrinolytic agents in spinal surgery: a network meta-analysis. Yuan L; Zeng Y; Chen ZQ; Zhang XL; Mai S; Song P; Tao LY Chin Med J (Engl); 2019 Mar; 132(5):577-588. PubMed ID: 30807356 [TBL] [Abstract][Full Text] [Related]
13. Is epsilon-aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery?: a meta-analysis. Munoz JJ; Birkmeyer NJ; Birkmeyer JD; O'Connor GT; Dacey LJ Circulation; 1999 Jan 5-12; 99(1):81-9. PubMed ID: 9884383 [TBL] [Abstract][Full Text] [Related]
14. Cost-benefit and efficacy of aprotinin compared with epsilon-aminocaproic acid in patients having repeated cardiac operations: a randomized, blinded clinical trial. Bennett-Guerrero E; Sorohan JG; Gurevich ML; Kazanjian PE; Levy RR; Barberá AV; White WD; Slaughter TF; Sladen RN; Smith PK; Newman MF Anesthesiology; 1997 Dec; 87(6):1373-80. PubMed ID: 9416723 [TBL] [Abstract][Full Text] [Related]
15. The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: a meta-analysis. Schouten ES; van de Pol AC; Schouten AN; Turner NM; Jansen NJ; Bollen CW Pediatr Crit Care Med; 2009 Mar; 10(2):182-90. PubMed ID: 19188875 [TBL] [Abstract][Full Text] [Related]
16. Preliminary investigation of high-dose tranexamic acid for controlling intraoperative blood loss in patients undergoing spine correction surgery. Xie J; Lenke LG; Li T; Si Y; Zhao Z; Wang Y; Zhang Y; Xiao J Spine J; 2015 Apr; 15(4):647-54. PubMed ID: 25457470 [TBL] [Abstract][Full Text] [Related]
17. Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies. Hutton B; Joseph L; Fergusson D; Mazer CD; Shapiro S; Tinmouth A BMJ; 2012 Sep; 345():e5798. PubMed ID: 22968722 [TBL] [Abstract][Full Text] [Related]
19. Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs. Penta de Peppo A; Pierri MD; Scafuri A; De Paulis R; Colantuono G; Caprara E; Tomai F; Chiariello L Tex Heart Inst J; 1995; 22(3):231-6. PubMed ID: 7580360 [TBL] [Abstract][Full Text] [Related]
20. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Laupacis A; Fergusson D Anesth Analg; 1997 Dec; 85(6):1258-67. PubMed ID: 9390590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]